hCD19/A20
CBPG0076
詢 價
留 言
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫
I. Background | |
CD19(Cluster of Differentiation 19)是一種跨膜糖蛋白,屬于免疫球蛋白超家族成員, 主要表達于 B 淋巴細胞譜系細胞表面,包括前 B 細胞、成熟 B 細胞及大多數(shù) B 細胞惡性腫 瘤細胞。其功能是作為 B 細胞受體(BCR)復合物的共受體,參與 B 細胞活化、增殖和分 化信號的傳導。CD19 作為 B 細胞惡性腫瘤的核心靶點,推動了 CAR-T 等精準免疫治療的 發(fā)展,顯著改善了患者預后。 | |
II. Introduction | |
Host Cell: | A20 |
Expressed gene: | hCD19 |
Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Culture Medium: | RPMI-1640+10%FBS+0.05 mM 2-mercaptoethanol+1 μg/ml Puromycin |
Mycoplasma Testing: | Negative |
Storage: | Liquid nitrogen |
III. Description of Host Cell Line | |
Organism: | Mus musculus, mouse |
Tissue: | B lymphocyte |
Morphology: | lymphoblast |
Growth Properties: | suspension |
IV. Representative Data | |
Figure 1. Recombinant hCD19/A20 stably expressing CD19. |
|